Chronic kidney disease (CKD) and end-stage renal disease (ESRD) represent significant mortality rates across the globe. Biorasi leverages our expertise in nephrology and project management to prevent potential obstacles and delays to CKD and rare nephrology disease trials including:
- Performance as a full-service nephrology CRO with expertise in CKD.
- Identification and recruitment of patients with specific nephropathies.
- Retention of enrolled patients and adherence to treatment.
- Capture and analysis of data across multiple mediums to inform trial results.
Bringing CKD recruitment under control
Biorasi’s recruitment expertise in nephrologysignificantly impacts enrollment and including access to global patient populations. Once patients have been screened and approved, we support our partners in trial participation solutions ranging from education and training to remote patient monitoring solutions.